So another JPMorgan Healthcare Conference is being held in USA -...

So another JPMorgan Healthcare Conference is being held in USA - from 8th - 11th of January 2018

Having looked at presenters and attendee's - officially Starpharma is not on the list

However as it is one of the largest networking events in biotech - I would suggest that there will be some management taking part in one form or another

Dr Tony Eglezos (business development) and CEO Jackie Fairley represented Starpharma's last year


So what else in January will we be looking forward to

Shareholder update not inclusive of items below (Chinese connection, Phase 2 clinical trial on nintedanib/Dep Docetaxel combination and Dep Docetaxel monotherapy, new agreements, new collabortions, etc etc, )
Quarterly cash flow report
Completion and forwarding last tract of NDA to FDA
Bacterial Vaginosis Formulation (Fleurstat) on retail shelves in Australia and New Zealand
Start of Dep Cabazitaxel Phase 1 trials
Possible preclinical data release on AZD0466 from AstraZeneca and initiation of Phase 1 clincal trial

I assure you - all the above could be reported on - without any exaggeration

Excitement is an understatement